178 related articles for article (PubMed ID: 32736008)
1. AT1R Activating Autoantibodies in Hematopoietic Stem Cell Transplantation.
Bradford KL; Pearl M; Kohn DB; Weng P; Yadin O; Bowles V; De Oliveira SN; Moore TB
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2061-2067. PubMed ID: 32736008
[TBL] [Abstract][Full Text] [Related]
2. Anti-Angiotensin type 1 receptor antibodies in chronic graft-versus-host disease.
Chiron A; Bouaziz JD; Carmagnat M; Peffault de Latour R; Lafaurie-Bergeron A; Robin M; Xhaard A; Toubert A; Charron D; Guigue N; Socié G; Bengoufa D
Transplantation; 2014 Aug; 98(4):470-4. PubMed ID: 24873781
[TBL] [Abstract][Full Text] [Related]
3. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
[TBL] [Abstract][Full Text] [Related]
4. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor.
Vythoulkas D; Lazana I; Kroupis C; Gavriilaki E; Konstantellos I; Bousiou Z; Chondropoulos S; Griniezaki M; Vardi A; Gkirkas K; Karagiannidou A; Batsis I; Stamouli M; Sakellari I; Tsirigotis P
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108124
[TBL] [Abstract][Full Text] [Related]
6. Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients.
Son BS; Lee HJ; Cho WH; So MW; Park JM; Yeo HJ
Transpl Immunol; 2023 Oct; 80():101901. PubMed ID: 37442212
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiotensin II type 1 receptor autoantibodies (AT
İlgen U; Yayla ME; Düzgün N
Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166
[TBL] [Abstract][Full Text] [Related]
8. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.
Li H; Kem DC; Zhang L; Huang B; Liles C; Benbrook A; Gali H; Veitla V; Scherlag BJ; Cunningham MW; Yu X
Hypertension; 2015 Apr; 65(4):793-9. PubMed ID: 25691619
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient.
Guzzo I; Morolli F; Camassei FD; Piazza A; Poggi E; Dello Strologo L
Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation.
Xu Q; McAlister VC; Leckie S; House AA; Skaro A; Marotta P
Am J Transplant; 2020 Jan; 20(1):282-288. PubMed ID: 31419065
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
Dragun D; Müller DN; Bräsen JH; Fritsche L; Nieminen-Kelhä M; Dechend R; Kintscher U; Rudolph B; Hoebeke J; Eckert D; Mazak I; Plehm R; Schönemann C; Unger T; Budde K; Neumayer HH; Luft FC; Wallukat G
N Engl J Med; 2005 Feb; 352(6):558-69. PubMed ID: 15703421
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
El Band JEK; Llorente S; Martinez-Garcia P; Alfaro R; Jimenez-Coll V; Boix F; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Minguela A; Legaz I; Muro M
Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
[TBL] [Abstract][Full Text] [Related]
13. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.
Kem DC; Li H; Velarde-Miranda C; Liles C; Vanderlinde-Wood M; Galloway A; Khan M; Zillner C; Benbrook A; Rao V; Gomez-Sanchez CE; Cunningham MW; Yu X
J Clin Endocrinol Metab; 2014 May; 99(5):1790-7. PubMed ID: 24552217
[TBL] [Abstract][Full Text] [Related]
15. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
Liu C; Kang ZY; Yin Z; Xiao Y; Liu W; Zhao Y; Li DH
Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
Giral M; Foucher Y; Dufay A; Duong Van Huyen JP; Renaudin K; Moreau A; Philippe A; Hegner B; Dechend R; Heidecke H; Brouard S; Cesbron A; Castagnet S; Devys A; Soulillou JP; Dragun D
Am J Transplant; 2013 Oct; 13(10):2567-76. PubMed ID: 23919486
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type I receptor antibodies in thoracic transplantation.
Zhang X; Reinsmoen NL
Hum Immunol; 2019 Aug; 80(8):579-582. PubMed ID: 30980862
[TBL] [Abstract][Full Text] [Related]
19. Non-HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation.
Chan AP; Guerra MR; Rossetti M; Hickey MJ; Venick RS; Marcus EA; McDiarmid SV; Farmer DG; Reed EF; Wozniak LJ
Pediatr Transplant; 2021 May; 25(3):e13987. PubMed ID: 33590644
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Anti-angiotensin II Type 1 Receptor Antibody-Associated Rejection in Kidney Transplantation: A Case Report.
Wiwattanathum P; Ingsathit A; Thammanichanond D; Worawichawong S
Transplant Proc; 2018 Apr; 50(3):877-880. PubMed ID: 29331505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]